RIVN three-lens brief
Evidence-based stock research on RIVN. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Underperforming SPY by 20.5pp over 30 days. · Currently unprofitable on a trailing basis — no P/E multiple available.
- Underperforming SPY by 20.5pp over 30 days.
- Currently unprofitable on a trailing basis — no P/E multiple available.
- Analyst mean target $18.15 — 30% above current (26 analysts).
- Negative free cash flow last quarterly (-$1.21B).
- Debt-to-equity of 113.4 — balance-sheet-heavy.
RIVN closed at $13.97 (+0.18%) as of 2026-05-13. Market cap: $18.77B. Positives: analyst mean target $18.15 — 30% above current (26 analysts).. Concerns: underperforming SPY by 20.5pp over 30 days.; currently unprofitable on a trailing basis — no P/E multiple available.. Last quarter: Revenue $1.38B, net income -$416.00M, free cash flow -$1.21B.
Why three lenses on RIVN, not one.
A single reasoning model has blind spots it doesn’t know about. We examine RIVNacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/RIVN" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath RIVN brief"></iframe>